بدائل البحث:
ng decrease » nn decrease (توسيع البحث), _ decrease (توسيع البحث), we decrease (توسيع البحث)
mg decrease » _ decrease (توسيع البحث), nn decrease (توسيع البحث), we decrease (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
59 a » 19 a (توسيع البحث), 59 0 (توسيع البحث), 5 a (توسيع البحث)
ng decrease » nn decrease (توسيع البحث), _ decrease (توسيع البحث), we decrease (توسيع البحث)
mg decrease » _ decrease (توسيع البحث), nn decrease (توسيع البحث), we decrease (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
59 a » 19 a (توسيع البحث), 59 0 (توسيع البحث), 5 a (توسيع البحث)
-
41
-
42
-
43
-
44
-
45
-
46
-
47
CM-DWM-EC chart using 30% decrease in the mean for the E(KeV).
منشور في 2024"…<p>CM-DWM-EC chart using 30% decrease in the mean for the E(KeV).</p>…"
-
48
-
49
-
50
Table_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to...
منشور في 2022"…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …"
-
51
Image_1_Anti-Mitochondrial Antibody Titers Decrease Over Time in Primary Biliary Cholangitis Patients With Ursodeoxycholic Acid Therapeutic Response: A Cohort Study Followed Up to...
منشور في 2022"…Patients with baseline cirrhosis (2.78 ± 2.56 vs. 6.84 ± 9.00 mg/dL, p=0.024) and UDCA nonresponders (2.54 ± 2.19 vs. 4.51 ± 6.99 mg/dL, p=0.006) had increased total bilirubin levels while patients without cirrhosis (AST: 91.5 ± 84.5 vs. 58.9 ± 43.7 U/L, p<0.001; ALT: 107.3 ± 122.5 vs. 50.7 ± 36.8 U/L, p<0.001) and UDCA responders (AST: 83.8 ± 101.3 vs. 45.58 ± 38.42 U/L, p=0.014; ALT: 95.10 ± 144.6 vs. 39.12 ± 30.65 U/L, p=0.009) had decreased aminotransferase levels. …"
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
Decreased clonogenic capacity of U87MG and U251MG glioma cells dependent on SHG-44 concentration.
منشور في 2025"…<b>(B)</b> A significant decrease in the proliferative clonal capacity of U251MG colonies was observed with 50ΜM and 100ΜM SHG-44 treatment. …"
-
60